Preventive effect of tumor necrosis factor inhibitors versus nonsteroidal anti-inflammatory drugs on uveitis in patients with ankylosing spondylitis
- 4 August 2018
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 37 (10) , 2763-2770
Abstract
To compare the preventive effect of tumor necrosis factor (TNF) inhibitors (anti-TNF antibody and soluble TNF receptor fusion protein (TNFR)) and nonsteroidal anti-inflammatory drugs (NSAIDs) on uveitis in patients with ankylosing spondylitis (AS). This retrospective cohort study included all AS patients (n = 1055) who have been treated with either TNF inhibitor or NSAIDs at the Seoul National University Hospital from 2004 to 2016. Treatment episodes of each patient were assigned to anti-TNF antibody (n = 517), TNFR (n = 341), and NSAID (n = 704) groups. The incidence of uveitis in each group was compared using a Cox proportional hazard model. The incidence rates of uveitis before and after initiation of TNF inhibitors were also assessed. A propensity score-matched (PSM) comparison was performed for a sensitivity analysis. Uveitis was significantly less common in the anti-TNF antibody group than the NSAID group (adjusted hazard ratio (HR) 0.53; 95% confidence interval (CI) 0.29–0.96) while it was higher in the TNFR group (adjusted HR 2.25, 95% CI 1.43–3.53). Anti-TNF antibody further reduced the incidence of uveitis when prescribed with NSAIDs (combination therapy) (adjusted HR 0.39; 95% CI 0.19–0.79). Combination therapy was preventive in AS patients with a history of uveitis (adjusted HR 0.31; 95% CI 0.12–0.81), but not in those without history of uveitis. The incidence rate of uveitis fell from 6.36 to 2.60 per 100 person-years when anti-TNF antibody was added to NSAIDs. Anti-TNF antibody plus NSAIDs reduces the risk of uveitis to a greater extent than NSAIDs alone in AS patients with a history of uveitis. Combination therapy may be an effective secondary prevention measure.Keywords
Funding Information
- Ministry of Education (2016R1D1A1A02937044)
This publication has 34 references indexed in Scilit:
- Different roles of TNF inhibitors in acute anterior uveitis associated with ankylosing spondylitis: state of the artClinical Rheumatology, 2016
- Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysisAnnals of the Rheumatic Diseases, 2015
- Associations among Visual Acuity and Vision- and Health-Related Quality of Life among Patients in the Multicenter Uveitis Steroid Treatment TrialInvestigative Ophthalmology & Visual Science, 2012
- Prevalence and factors associated with uveitis in spondylarthritis patients in France: Results from an observational surveyArthritis Care & Research, 2012
- Cigarette Smoking as a Risk Factor for UveitisOphthalmology, 2010
- Analysis of uveitis rates across all etanercept ankylosing spondylitis clinical trialsAnnals of the Rheumatic Diseases, 2010
- Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature reviewAnnals of the Rheumatic Diseases, 2008
- Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitisAnnals of the Rheumatic Diseases, 2006
- UveitisBest Practice & Research Clinical Rheumatology, 2006
- Acute Anterior Uveitis and HLA-B27Survey of Ophthalmology, 2005